Moreover, SHP-1 has been demonstrated to be overexpressed in non-cancer tissues compared with surrounding cancer tissues, and reduced SHP-1 expression is highly associated with poor prognosis of patients with HCC (85). This evidence concerns the gene PTPN6 and hepatocellular carcinoma.